- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Bullion Gold Resources Corporation: Bullion Gold Obtains Drilling Permits for the Langlade Project | 280 | Newsfile | Montreal, Quebec--(Newsfile Corp. - February 26, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Corporation") announces that it has received approval from the Quebec Ministry... ► Artikel lesen | |
| 17.02. | Bullion Gold Resources Corporation: Diamond Drilling Intersects Multiple Visible Gold Occurrences at the Bousquet Gold Project | 435 | Newsfile | Montreal, Quebec--(Newsfile Corp. - February 17, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") and it's partner Olympio Metals are pleased to announce that the... ► Artikel lesen | |
| 13.02. | Bullion Gold Resources Corp (2): Bullion Gold restarts drilling at Bousquet project | 1 | Stockwatch | ||
| 12.02. | Bullion Gold Resources Corporation: Drilling Resumes at Bousquet Gold Project, Quebec | 277 | Newsfile | Montréal, Québec--(Newsfile Corp. - February 12, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is pleased to announce that it's partner Olympio Metals ("Olympio")... ► Artikel lesen | |
| 12.02. | XFRA NEW INSTRUMENTS AVAILABLE ON 12.02.2026 | 267 | Xetra Newsboard | The following instruments on XETRA do have their first trading 12.02.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 12.02.2026
Aktien
1 CA13723D1006 Canasil Resources Inc.
2... ► Artikel lesen | |
| 03.02. | Bullion Gold Resources Corp (2): Bullion Gold acquisition of Abitibi mining claims | 1 | Stockwatch | ||
| BULLION GOLD RESOURCES Aktie jetzt für 0€ handeln | |||||
| 27.01. | Bullion Gold Resources Corp (2): Bullion Gold takes 100% ownership of Terragold | 2 | Stockwatch | ||
| 26.01. | Bullion Gold Resources Corporation: Bullion Gold Acquires 100% of the Terragold Project and Consolidates a Strategic Gold Asset | 284 | Newsfile | Montreal, Quebec--(Newsfile Corp. - January 26, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is pleased to announce the signing of an amendment to the original... ► Artikel lesen | |
| 09.01. | Bullion Gold Resources Corp (2): Bullion Gold private placement | 2 | Stockwatch | ||
| 06.01. | Bullion Gold Resources Corporation: High-Grade Gold up to 12.2 g/t Intersected in Multiple Structures at Bousquet | 518 | Newsfile | Montreal, Quebec--(Newsfile Corp. - January 6, 2026) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Corporation") is pleased to announce further assay results for the Bousquet... ► Artikel lesen | |
| 24.12.25 | Bullion Gold Resources Corp (2): Bullion Gold closes $300,000 private placement | 2 | Stockwatch | ||
| 23.12.25 | Bullion Gold Resources Corporation: Bullion Gold Completes Private Placement | 399 | Newsfile | Montreal, Quebec--(Newsfile Corp. - December 23, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Corporation") announces that it has closed a private placement (the "Offering")... ► Artikel lesen | |
| 02.12.25 | Bullion Gold Resources Corporation: Bullion Gold Presents the Historical Overview of Its Terragold Gold Project | 419 | Newsfile | Montreal, Quebec--(Newsfile Corp. - December 2, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "the Corporation") will soon file an ATI permit application for a stripping and drilling... ► Artikel lesen | |
| 26.11.25 | Bullion Gold Resources Corporation: Bullion Gold Acquires the Transterre, Transterre-Ouest, and Candore Gold Projects (Forming the Terragold Project) | 495 | Newsfile | Montreal, Quebec--(Newsfile Corp. - November 26, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "the Corporation") is pleased to announce the signing of an acquisition agreement... ► Artikel lesen | |
| 14.11.25 | Bullion Gold Resources Corp (2): Bullion begins survey at Langlade, appoints director | 1 | Stockwatch | ||
| 13.11.25 | Bullion Gold Resources Corporation: Bullion Gold Begins Geochemical Survey of Base Till on Langlade and Appoints a New Director to Its Board | 466 | Newsfile | Montreal, Quebec--(Newsfile Corp. - November 13, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "The Company") is proud to announce the launch of an intensive follow-up program... ► Artikel lesen | |
| 29.10.25 | Bullion Gold Resources Corp (2): Bullion Gold private placement | 1 | Stockwatch | ||
| 28.10.25 | Bullion Gold Resources Corporation: 1.7km Gold System Emerging at Decoeur | 441 | Newsfile | Montreal, Quebec--(Newsfile Corp. - October 28, 2025) - Bullion Gold Resources (TSXV: BGD) ("Bullion Gold" or "The Company") is pleased to further assay results have been received for the Decoeur Prospect... ► Artikel lesen | |
| 22.10.25 | Bullion Gold Resources Corp (2): Bullion hires ITG as market-maker, arranges financing | 1 | Stockwatch | ||
| 21.10.25 | Bullion Gold Resources Corporation: Bullion Gold Engages Independent Trading Group as Market Maker, Announces Private Placement. | 1.106 | Newsfile | Montreal, Quebec--(Newsfile Corp. - October 21, 2025) - Bullion Gold Resources (TSXV: BGD) ("Bullion Gold" or "The Company") announces that, subject to regulatory approval, it has engaged the services... ► Artikel lesen |
1 2 3 Weiter >>
42 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| VIR BIOTECHNOLOGY | 9,340 | 0,00 % | Vir Biotechnology +70%: Deal-Überraschung mit Ansage | Die Aktie von Vir Biotechnology ist vorbörslich um rund 70 Prozent nach oben geschossen. Auslöser der Kursexplosion ist vor allem ein milliardenschwerer Kooperationsdeal mit dem japanischen Pharmakonzern... ► Artikel lesen | |
| ARCELLX | 114,05 | +0,22 % | Weekly Buzz: MGNX's LINNET Trial On Hold; Eton Pharmaceuticals, ALUR Get FDA Nod; GILD Snaps Up ACLX | FOSTER CITY (dpa-AFX) - This week, the biotech space witnessed significant milestones, including FDA approvals, oncology drug acquisitions, and collaborations. Positive clinical trial results... ► Artikel lesen | |
| KYMERA THERAPEUTICS | 90,10 | 0,00 % | Morgan Stanley cuts Kymera Therapeutics stock price target on pipeline progress | ||
| BEAM THERAPEUTICS | 28,690 | +0,74 % | Beam Therapeutics Announces $500 Million Strategic Financing Facility with Sixth Street | $100 Million Funded at Close with up to an Additional $400 Million Available Under Facility with Seven-Year Term Financing Bolsters Balance Sheet with Long-term, Non-dilutive Capital to Support Anticipated... ► Artikel lesen | |
| QIAGEN | 41,295 | -1,58 % | Shortseller-Positionen aktuell: freenet, GFT, HelloFresh, Hypoport, Puma, Qiagen, Redcare Pharmacy | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| VERA THERAPEUTICS | 40,420 | -0,98 % | Vera Therapeutics, Inc. - 10-K, Annual Report | ||
| ARCUTIS BIOTHERAPEUTICS | 24,760 | -8,25 % | Arcutis Biotherapeutics, Inc.: Arcutis Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update | Q4 2025 net product revenue for ZORYVE (roflumilast) was $127.5 million, an 84% increase compared to Q4 2024, and a 29% increase compared to Q3 2025Full year 2025 net product revenue for ZORYVE was... ► Artikel lesen | |
| ERASCA | 14,530 | +6,45 % | Erasca, Inc.: Erasca Announces Issuance of a U.S. Patent Covering Pan-KRAS Inhibitor ERAS-4001 | The issued patent provides intellectual property protection for ERAS-4001 and related compositions until at least 2043 Expands Erasca's diversified IP portfolio for RAS-driven cancers Initial Phase... ► Artikel lesen | |
| RECURSION PHARMACEUTICALS | 3,630 | 0,00 % | Recursion Pharmaceuticals: Recursion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update | Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI-driven biological insight to meaningful patient outcomes; multiple clinical... ► Artikel lesen | |
| ADMA BIOLOGICS | 16,580 | 0,00 % | ADMA Biologics Announces $200 Mln Capital Return Plan | ||
| TREVI THERAPEUTICS | 12,570 | +5,54 % | Trevi Therapeutics, Inc.: Trevi Therapeutics Announces Appointment of David Hastings as Chief Financial Officer | Experienced biotech CFO to lead financial strategy and contribute to the Company's next stage of growth
NEW HAVEN, Conn., Dec. 4, 2025 /PRNewswire/ -- Trevi Therapeutics... ► Artikel lesen | |
| APOGEE THERAPEUTICS | 70,92 | +1,26 % | RBC Capital lowers Apogee Therapeutics stock price target on dosing outlook | ||
| BIONTECH | 92,30 | +0,27 % | BioNTech Aktie: Die Wende naht! Golden Cross! | © Foto: 2026 BioNTech SE. Alle Recht vorbehalten.Fast wie in der Serie "Game of Thrones", wo der Winter naht, könnte bei BioNTech die Wende nahen. Nach dem Kursrausch in der Corona-Ära folgte der brutale... ► Artikel lesen | |
| PRAXIS PRECISION MEDICINES | 330,19 | -1,95 % | Praxis Precision Medicines, Inc.: Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results | Two new drug applications (NDA) for ulixacaltamide in essential tremor (ET) and for relutrigine in SCN2A and SCN8A developmental and epileptic encephalopathies (DEEs) have been submitted to the U.S.... ► Artikel lesen | |
| TYRA BIOSCIENCES | 32,520 | -2,63 % | Tyra Biosciences GAAP EPS of -$0.57 misses by $0.04 |
BULLION GOLD RESOURCES CORPORATION gehört der Branche Biotechnologie an. Mit einer aktuellen Kursveränderung von +0,000 (+0,77 %) liegt der Kurs bei 0,052 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BULLION GOLD RESOURCES CORPORATION finden Sie auf Wallstreet Online.